meganuclease Cellectis, Precision Biosciences File Suits Against Each Other Again NEW YORK (GenomeWeb News) – French firm Cellectis and North Carolina-based Precision Biosciences have filed two new suits against each other alleging infringement of US patents covering modified meganucleases. Helix BioService to Promote Cellectis Products in India Helix will promote Cellectis' Genome Positioning System line of products and services in India. Cellectis Acquires Cyto Pulse Assets for $2M The French firm gains access to Cyto Pulse's electroporation technologies and equipment. Cellectis Bioresearch Inks Canadian Distribution Deal Cedarlane will distribute Cellectis Bioresearch's kits in Canada. Cellectis, Precision Bio Differ on EPO Decision Regarding Gene-Engineering Patent The patent has been the subject of ongoing litigation between the French and US biotech firms. Sep 1, 2009 Monsanto Licenses Cellectis Technology for Genome Modifications Breaking News People in the News at Probius, Flagship Biosciences, Discovery Life Sciences, More New Products Posted to GenomeWeb: BillionToOne, Becton Dickinson, Enzo Biochem, More Stroke Risk Contributors, Treatment Targets Uncovered in Cross-Ancestry GWAS In Brief This Week: Yourgene Health, Bionano Laboratories, Caris Life Sciences, More Enzymatic RNA Synthesis Firm EnPlusOne Biosciences Launches With $12M in Seed Funding The Scan Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says. Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds. Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry. UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.